The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China

Background: Improving drug accessibility and rational drug use are major challenges for China’s healthcare reform. In 2018, the Chinese government introduced a novel nationwide policy of centralized drug procurement for off-patent drugs, focusing on improving drug utilization patterns of public medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiancheng, Long, Hongfei, Shen, Yuan, Wang, Jing, Geng, Xin, Yang, Ying, Mao, Zongfu, Li, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445493/
https://www.ncbi.nlm.nih.gov/pubmed/36081942
http://dx.doi.org/10.3389/fphar.2022.923209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445493/
https://www.ncbi.nlm.nih.gov/pubmed/36081942
http://dx.doi.org/10.3389/fphar.2022.923209

Ejemplares similares